Infantile idiopathic myopathic carnitine deficiency: treatment with L-carnitine

Pediatr Neurol. 1993 Jan-Feb;9(1):35-8. doi: 10.1016/0887-8994(93)90007-y.

Abstract

A series of 9 infants, ranging in age from 3 months to 5 years (average: 2 years), suffered from idiopathic myopathic carnitine deficiency presenting as hypotonia and motor delay. Secondary carnitine deficiency was eliminated by appropriate tests. Muscle carnitine concentration ranged from 2.3-7.1 nmol/mg non-collagen protein (NCP; average: 4.87 nmol/mg NCP; normal: 22 +/- 6 nmol/mg NCP). Lipid accumulation in muscle was observed in 2 of 8 patients. Therapy with L-carnitine (100 mg/kg/day in most patients) was given with clinical and laboratory follow-up 6 months later. In 7 of 9 patients, muscle tone and motor function improved. Muscle carnitine concentration increased to a range of 2.7-23.4 nmol/mg (average: 12.27 nmol/mg). In some patients the muscle carnitine content multiplied by a factor of 3-4, but carnitine concentration reached the normal range in only 2 patients. Most infants with idiopathic carnitine deficiency did benefit from 6 months of therapy; however, in order to achieve full recovery the duration of therapy should probably continue for longer periods, with a dose of not less than 100 mg/kg/day.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Carnitine / analysis
  • Carnitine / deficiency*
  • Carnitine / therapeutic use*
  • Child
  • Child, Preschool
  • Electromyography
  • Female
  • Humans
  • Infant
  • Male
  • Muscles / chemistry
  • Muscles / pathology
  • Muscular Diseases / drug therapy*
  • Muscular Diseases / pathology
  • Muscular Diseases / physiopathology

Substances

  • Carnitine